 NEW YORK, July 26, 2021 PRNewswire -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Athira Pharma, Inc. NASDAQ: ATHA: a pursuant andor traceable to the Companys initial public offering conducted in September 2020 the IPO or Offering; andor b between September 18, 2020 and June 17, 2021, both dates inclusive the Class Period, of the important August 24, 2021 lead plaintiff deadline. SO WHAT: If you purchased Athira securities pursuant andor traceable to the Companys IPO andor during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. 